Literature DB >> 68239

Labetalol in hypertension.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 68239

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Hemiparesis after single minibolus of labetalol for hypertensive encephalopathy.

Authors:  R Solomons
Journal:  Br Med J       Date:  1979-09-15

Review 2.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

3.  Treatment of severe hypertension by repeated bolus injections of labetalol.

Authors:  A M Cumming; J J Brown; A F Lever; A Mackay; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 4.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 5.  Comparison of labetalol with other anti-hypertensive drugs.

Authors:  B N Prichard; D A Richards
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

6.  Rapid reduction of blood pressure with acute oral labetalol.

Authors:  A B Davies; V Bala Subramanian; B Gould; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

7.  Treatment of hypertensive emergencies with oral labetalol.

Authors:  R R Ghose; Y B Mathur; M Upadhyay; W D Morgan; S Khan
Journal:  Br Med J       Date:  1978-07-08

8.  Intravenous labetalol in severe hypertension.

Authors:  C Dal Palu; A C Pessina; A Semplicini; M Hlede; F Morandin; P Palatini; G Sperti; G P Rossi
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

9.  Intravenous labetalol in the treatment of severe hypertension.

Authors:  A M Cumming; J J Brown; A F Lever; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

10.  Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.

Authors:  A M Cummings; J J Brown; R Fraser; A F Lever; J J Morton; D A Richards; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.